NousCom raises €42mSwiss oncolytic virus and vaccine specialist NousCom has closed a €42m Series B financing round led by new investor Abingworth. Co-investors include new 5AM Ventures, and existing investors LSP and … more ➔
Blocking antibody recycling vs autoimmune...Researchers at Belgian UCB SA have clinically demonstrated that an antibody targeting a normal cellular recycling process can remove autoantibodies from the blood of people with autoimmune diseases. … more ➔
Another death related to allogenic CAR-T c...Following the death of a patient with blastic plasmacytoid dendritic cell neoplasm (BPDCN), the FDA put a hold on two clinical Phase I trials with UCART123, French Cellectis SAs allogenic CAR-T therapies. … more ➔
BioGeneration Ventures Fund III closed at...Dutch venture capital company BioGeneration Ventures (BGV) has closed its third fund, BGV III, at €82m exceeding the original target by €32m. more ➔
Ablynx IPO Ablynx raises US$230mBelgian nanobody producer Ablynx closes an initial public offering of American Depositary Shares at Nasdaq totalling US$200m plus a fully exercised greenshoe option amounting aggregate gross … more ➔
CPHI, CPHI Worldwide, pharma professionals CPHI Worldwide expands outreach The worlds largest event for pharma professionals, CPHI worldwide, will see an expansion to the rapidly-growing field of biologics next year in Madrid more ➔
Biotech Ireland, Limerick County, Regeneron Pharmaceuticals 300 jobs more: US company expands its Iris... US biotech company Regeneron Pharmaceuticals revealed plans to create some 300 new jobs in Ireland’s Limerick County. The jobs form part of a US$100m (€85m) expansion plan for the company’s campus … more ➔
Bill & Melinda Gates Foundation, Immunethep, portuegese biotech Immunethep receives grant from Gates Found... Portuguese biotech company Immunethep has convinced the Bill & Melinda Gates Foundation to hand out a grant to test its antibody against the bacterial extracellular virulence factor GAPDH. more ➔
cd46 protein, multiple sclerosis EU researchers unveil how T cell dysfuncti...French and British scientists have revealed insight into how a critical immune regulatory pathway contributes to the development of multiple sclerosis (MS), potentially paving the way toward future immunotherapies … more ➔
Uniqure readies share stock offering Dutch Uniqure BV launched a public offering of five million shares of common stock. Underwriters over-allotment will be an additional 750,000 shares. more ➔
